Glenmark Pharmaceuticals gets final approval for Tacrolimus Ointment, 0.1%

From USFDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Ointment, 0.1%, the generic version of Protopic1 Ointment, 0.1%, of Leo Pharma AS.

According to IQVIATM sales data for the 12 month period ending February 2018, the Protopic Ointment, 0.1% market2 achieved annual sales of approximately $109.0 million*.

Powered by Capital Market - Live News